[1]Baidoun F, Elshiwy K, Elkeraie Y, et al. Colorectal cancer epidemiology: recent trends and impact on outcomes[J]. Curr Drug Targets, 2021, 22(9): 998-1009. DOI: 10.2174/1389450121999201117115717.
[2]Dougherty MW, Jobin C. Intestinal bacteria and colorectal cancer: etiology and treatment[J]. Gut Microbes, 2023, 15(1): 2185028. DOI: 10.1080/19490976.2023.2185028.
[3]刘子豪,张娜,李昉璇,等.同型半胱氨酸凝血功能指标与结直肠癌发病风险相关性的病例对照研究[J].中国肿瘤临床, 2023, 50(13):654-660. DOI: 10.12354/j.issn.1000-8179.2023.20230289.
[4]张梦,丁光辉,代博雅.慢性阻塞性肺疾病急性发作期患者肠道菌群特征及血清同型半胱氨酸、白介素-6对其肠道菌群失调的预测效能[J].中国微生态学杂志, 2023, 35(10):1187-1191. DOI: 10.13381/j.cnki.cjm.202310012.
[5]Xu J, Yu M, Fan W, et al. A novel gene signature related to fatty acid metabolism predicts prognosis, immune landscape, and drug sensitivity in early-stage lung squamous cell carcinoma [J]. Transl Cancer Res, 2024, 13(2): 525-541. DOI: 10.21037/tcr-23-1640.
[6]Cheung EC, Vousden KH. The role of ROS in tumour development and progression[J]. Nat Rev Cancer, 2022, 22(5): 280-297. DOI: 10.1038/s41568-021-00435-0.
[7]中华人民共和国国家卫生健康委员会.中国结直肠癌诊疗规范(2020版)[J].中华消化外科杂志, 2020, 19(6):563-588. DOI: 10.3760/cma.j.cn115610-20200504-00348.
[8]杜生旺,史春强,吴新军,等.腹腔镜术前口服高糖溶液对结直肠癌患者的影响[J].国际医药卫生导报, 2024, 30(4):606-609. DOI: 10.3760/cma.j.issn.1007-1245.2024.04.017.
[9]Zhao H, Ming T, Tang S, et al. Wnt signaling in colorectal cancer: pathogenic role and therapeutic target[J]. Mol Cancer, 2022, 21(1):144. DOI: 10.1186/s12943-022-01616-7.
[10]Han M, Sun H, Zhou Q, et al. Effects of RNA methylation on tumor angiogenesis and cancer progression[J]. Mol Cancer, 2023, 22(1):198. DOI: 10.1186/s12943-023-01879-8.
[11]Palaskar S, Joshi K, Mukkanwar R, et al. Utility of serum homocysteine in oral squamous cell carcinoma patients as a potential biomarker[J]. J Oral Maxillofac Pathol, 2022, 26(3): 335-339. DOI: 10.4103/jomfp.jomfp_268_22.
[12]Xie H, Wei L, Wang Q, et al. Elevated serum homocysteine levels associated with poor recurrence-free and overall survival in patients with colorectal cancer[J]. Sci Rep, 2024, 14(1): 10057. DOI: 10.1038/s41598-024-60855-4.
[13]卜旻淳,曹先东,周波,等.基于TCGA数据库构建胃癌免疫相关基因的预后风险模型[J].临床肿瘤学杂志, 2022, 27(7):616-621. DOI: 10.3969/j.issn.1009-0460.2022.07.007.
[14]Li S, Qu Y, Liu L, et al. Comparative proteomic profiling of plasma exosomes in lung cancer cases of liver and brain metastasis[J]. Cell Biosci, 2023, 13(1):180. DOI: 10.1186/s13578-023-01112-5.
[15]侯志娟,文普帅.转移性结直肠癌患者总生存期的相关新基因APOH、KNG1和FGG[J].中国医科大学学报, 2023, 52(2):126-131. DOI: 10.12007/j.issn.0258-4646.2023.02.006.
[16]Jelic MD, Mandic AD, Maricic SM, et al. Oxidative stress and its role in cancer[J]. J Cancer Res Ther, 2021, 17(1): 22-28. DOI: 10.4103/jcrt.JCRT_862_16.
[17]Singh V, Ahlawat S, Mohan H, et al. Balancing reactive oxygen species generation by rebooting gut microbiota [J]. J Appl Microbiol, 2022, 132(6): 4112-4129. DOI: 10.1111/jam.15504.
[18]Sahoo BM, Banik BK, Borah P, et al. Reactive oxygen species (ROS): key components in cancer therapies [J]. Anticancer Agents Med Chem, 2022, 22(2): 215-222. DOI: 10.2174/1871520621666210608095512.
[19]Sorolla MA, Hidalgo I, Sorolla A, et al. Microenvironmental reactive oxygen species in colorectal cancer: involved processes and therapeutic opportunities[j]. Cancers (Basel), 2021, 13(20): 5037. DOI: 10.3390/cancers13205037.
[20]Wong CC, Yu J. Gut microbiota in colorectal cancer development and therapy[J]. Nat Rev Clin Oncol, 2023, 20(7): 429-452. DOI: 10.1038/s41571-023-00766-x.
[21]赵梓汝,李业荣,贾海英,等.高同型半胱氨酸血症人群的肠道菌群特征研究[J].中国临床保健杂志, 2022, 25(5):672-677. DOI: 10.3969/J.issn.1672-6790.2022.05.021.
[22]Hoekstra M, Chen HY, Rong J, et al. Genome-wide association study highlights APOH as a novel locus for lipoprotein(a) levels-brief report[J]. Arterioscler Thromb Vasc Biol, 2021, 41(1): 458-464. DOI: 10.1161/ATVBAHA.120.314965.
[23]Liu Y, Zhao Y, Liu Q, et al. Effects of apolipoprotein H downregulation on lipid metabolism, fatty liver disease, and gut microbiota dysbiosis [J]. J Lipid Res, 2024, 65(1):100483. DOI: 10.1016/j.jlr.2023.100483.
[24]Hou Y, Wang H, Wu J, et al. Dissecting the pleiotropic roles of reactive oxygen species (ROS) in lung cancer: from carcinogenesis toward therapy[J]. Med Res Rev, 2024, 44(4):1566-1595. DOI: 10.1002/med.22018.
[25]Shin Y, Han S, Kwon J, et al. Roles of short-chain fatty acids in inflammatory bowel disease [J]. Nutrients, 2023, 15(20): 4466. DOI: 10.3390/nu15204466.
|